Investors
|
Join Our Team
Immune Medicine
Immune Medicine Platform
The Adaptive Immune System
Research Publications
Products & Pipeline
Life Sciences Research
immunoSEQ
immunoSEQ T-MAP
Clinical Diagnostics
clonoSEQ
T-Detect
Drug Discovery
Cellular Therapy
Neutralizing Antibodies
Vaccines
Pipeline
Clinical Portfolio & Pipeline
Partners
Biopharma Partners
Technology Partners
News & Events
MEDIA
Press Releases
Media Resources
BLOG
Powering the Age of Immune Medicine
The Case for T cells
Great News for Blood Cancer Patients
A Testing Renaissance
See all posts
events
Conferences & Events
Webinars
Our Science
Clinical Studies
ImmuneRACE
ImmuneSense Lyme
medical
Medical Affairs
Medical Information
Data & Congresses
DATA PROGRAMS
ImmuneCODE
ImmuneACCESS
PUBLICATIONS
Research Publications
EDUCATION
SEQDiscovery
About Us
ABOUT US
Who We Are
Our Story
Innovation Timeline
Leadership
INVESTORS
Investor Relations
Newsroom
CONNECT
Contact
Careers
IMMUNE MEDICINE
Immune Medicine Platform
The Adaptive Immune System
Research Publications
PRODUCTS & PIPELINE
LIFE SCIENCES RESEARCH
immunoSEQ
immunoSEQ T-MAP
CLINICAL DIAGNOSTICS
clonoSEQ
T-Detect
DRUG DISCOVERY
Cellular Therapy
Neutralizing Antibodies
Vaccines
PIPELINE
Clinical Portfolio & Pipeline
PARTNERS
Biopharma Partners
Technology Partners
NEWS & EVENTS
MEDIA
Press Releases
Media Resources
BLOG
Powering the Age of Immune Medicine
The Case for T Cells
Great News for Blood Cancer Patients
A Testing Renaissance
See all posts ➔
EVENTS
Conferences & Events
Webinars
OUR SCIENCE
CLINICAL
ImmuneRACE
ImmuneSense Lyme
MEDICAL
Medical Affairs
Medical Information
Data & Congresses
DATA PROGRAMS
ImmuneCODE
ImmuneACCESS
PUBLICATIONS
Research Publications
ABOUT US
ABOUT US
Who We Are
Our Story
Innovation Timeline
Leadership
INVESTORS
Investor Relations
Newsroom
CONNECT
Contact
Careers
Menu
IMMUNE MEDICINE
Immune Medicine Platform
The Adaptive Immune System
Research Publications
PRODUCTS & PIPELINE
LIFE SCIENCES RESEARCH
immunoSEQ
immunoSEQ T-MAP
CLINICAL DIAGNOSTICS
clonoSEQ
T-Detect
DRUG DISCOVERY
Cellular Therapy
Neutralizing Antibodies
Vaccines
PIPELINE
Clinical Portfolio & Pipeline
PARTNERS
Biopharma Partners
Technology Partners
NEWS & EVENTS
MEDIA
Press Releases
Media Resources
BLOG
Powering the Age of Immune Medicine
The Case for T Cells
Great News for Blood Cancer Patients
A Testing Renaissance
See all posts ➔
EVENTS
Conferences & Events
Webinars
OUR SCIENCE
CLINICAL
ImmuneRACE
ImmuneSense Lyme
MEDICAL
Medical Affairs
Medical Information
Data & Congresses
DATA PROGRAMS
ImmuneCODE
ImmuneACCESS
PUBLICATIONS
Research Publications
ABOUT US
ABOUT US
Who We Are
Our Story
Innovation Timeline
Leadership
INVESTORS
Investor Relations
Newsroom
CONNECT
Contact
Careers
Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 MutationComparison With Pediatric Patients
STAY IN TOUCH
Receive the latest
Adaptive news and updates
Notice: JavaScript is required for this content.
Your email is safe with us. Read our
Privacy Policy
.
Adaptive is ringing in the new year with a new identity
Read More